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Induction of trained immunity (innate immune mem-
ory) is mediated by activation of immune and meta-
bolic pathways that result in epigenetic rewiring of
cellular functional programs. Through network-level
integration of transcriptomics and metabolomics
data, we identify glycolysis, glutaminolysis, and the
cholesterol synthesis pathway as indispensable for
the induction of trained immunity by b-glucan in
monocytes. Accumulation of fumarate, due to gluta-
mine replenishment of the TCA cycle, integrates im-
mune and metabolic circuits to induce monocyte
epigenetic reprogramming by inhibiting KDM5 his-
tone demethylases. Furthermore, fumarate itself
induced an epigenetic program similar to b-glucan-
induced trained immunity. In line with this, inhibition
of glutaminolysis and cholesterol synthesis in mice
reduced the induction of trained immunity by
b-glucan. Identification of the metabolic pathways
leading to induction of trained immunity contributes
to our understanding of innate immune memory
and opens new therapeutic avenues.
INTRODUCTION
Recent studies demonstrated that certain infections and vacci-
nations induce innate immune memory (also termed trained im-Ce
This is an open access article under the CC BY-Nmunity; Netea et al., 2016) in monocytes, macrophages, and
natural killer cells, resulting in non-specific protection against
reinfection (Quintin et al., 2012; Sun et al., 2009). The biological
relevance of innate immune memory is demonstrated by its
broad presence in nature, with studies in organisms as diverse
as plants, insects, cephalopods, and mammals reporting its
impact for resistance to infections (Fu and Dong, 2013; Kurtz,
2005; Netea et al., 2011). Many of the studies reporting adaptive
characteristics embedded in innate immune responses predate
the modern era of molecular biology: the lack of understanding
the molecular mechanisms underlying their effects impaired,
however, the capacity to fully understand the importance of
this process. This situation has changed profoundly over the
last few years, when several studies demonstrated that epige-
netic reprogramming forms the basis of innate immune memory
in both plants (Muthamilarasan and Prasad, 2013; Shah et al.,
2014) and mammals (Kleinnijenhuis et al., 2012; O’Sullivan
et al., 2015; Quintin et al., 2012; Saeed et al., 2014).
Genome-wide changes in histone modifications have been
shown to underlie trained immunity inmonocytes, but themolec-
ular mechanisms linking the immunological signals induced by
microbial stimuli or vaccines to the epigenetic changes have
not been deciphered. Changes in cellular metabolism, with a
shift from oxidative phosphorylation to aerobic glycolysis (War-
burg effect), are crucial for the induction of b-glucan-induced
trained immunity (Cheng et al., 2014). Interestingly, increasing
evidence links cellular metabolism to the regulation of gene tran-
scription, as several metabolites from glycolysis and the TCA cy-
cle have been shown to act as cofactors for epigenetic writers
and erasers such as DNA and histone methyltransferases andll Metabolism 24, 1–13, December 13, 2016 ª 2016 Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Donohoe and Bultman, 2012; Hirschey et al., 2015). These cir-
cuits have important functional consequences based on how
cells use metabolic substrates: for example, type 1 inflammatory
macrophages (M[IFNg]) rely on increased glycolysis (Mills and
O’Neill, 2015; Pearce et al., 2013; Tan et al., 2015), whereas
tolerantmacrophages (M[IL-4]) rely on oxidative phosphorylation
and b-oxidation (Mills and O’Neill, 2015; Van den Bossche et al.,
2015). Interestingly, not only glucose metabolism, but also other
metabolic pathways play important roles in reprogramming and
polarizing cells (Cheng et al., 2016; Donohoe and Bultman, 2012;
Hirschey et al., 2015).
Based on this growing body of evidence, we hypothesized that
changes in cellular metabolism in trained immunity not only
reflect enhanced energetic needs, but also connect with immune
pathways and epigenetic reprogramming, through the accumu-
lation of specific metabolites modulating epigenetic processes
that impact the functional program of the cell. We combined
transcriptomic, metabolomic, and epigenomic studies to identify
important metabolic processes activated in b-glucan-trained
monocytes. We validated the role of these processes in induc-
tion of trained immunity, identifying an important function for
glutamine metabolism and fumarate accumulation. The impor-
tance of these processes was also demonstrated in in vivo
models of trained immunity.
RESULTS
Cellular Metabolic Pathways in Monocytes during
Induction of Trained Immunity
b-glucan and bacterial lipopolysaccharide (LPS) induce different
long-term functional programs in monocytes and macrophages;
i.e., enhanced function and tolerance, respectively; with tran-
scriptomic and epigenomic analyses revealing major differences
in glucose metabolism pathways (Cheng et al., 2014; Saeed
et al., 2014). To elucidate whether additional metabolic path-
ways are differentially expressed between trained and tolerant
cells, RNA-sequencing (seq) expression data at different time
points after stimulation with b-glucan and LPS were analyzed
for metabolic pathways and full intracellular metabolome
assessment was performed. We used the previously described
in vitro model of trained immunity (Cheng et al., 2014) in which
purified monocytes are stimulated for 24 hr with RPMI, b-glucan,
or LPS, after which cells are washed and rested for 5 days in cul-
ture medium, followed by a second 24 hr stimulation with either
medium or LPS (Figure S1). Distinct RNA expression patterns
between b-glucan-trained and non-trained (RPMI) cells wereFigure 1. Metabolism in Trained and Tolerant Macrophages
(A) Heatmap depicting average mRNA expression of b-glucan-modulated metab
columns indicate different conditions and time points. Log(e)RPKM values were
indicating low RNA expression. The PCA plot shows the relationship between sam
(triangles), and b-glucan (squares) samples are shown at 24 hr (green) and day 6
(B) Heatmap depicting the average metabolite intensities in the metabolomics da
conditions. The log transformed metabolite intensities were first Z scored/standa
PC2 of the standardized metabolomics data is shown. The samples are color-cod
after stimulation. See also Figure S1 and Tables S2 and S3.
(C) Schematic pathway map depicting gene expression (arrows) and metabolic
transcripts and metabolites marked in red were significantly upregulated in b-
Figure S1.visible after 24 hr of stimulation, with the largest differences
observed at the day 6 time point in LPS-treated cells (Figure 1A;
Table S1). Metabolome data of trained and tolerant cells showed
that at early time points (4 hr and 24 hr after stimulation), only
small differences existed between the three conditions (RPMI,
LPS, b-glucan). On day 6, however, the intracellular metabolome
of b-glucan-trained cells was clearly different from the RPMI
and LPS-treated cells, with major differences observed in
TCA cycle metabolites, fatty acid metabolism, and other
pathways (Figures 1B and S1; Tables S2 and S3). Altogether,
these data indicate that the majority of transcriptional changes
associated with metabolic pathways occur early (24 hr) in
b-glucan-exposed cells and precede the metabolic phenotype
observed in fully differentiated b-glucan-trained macrophages
on day 6.
Integration of the transcriptome and metabolome data in a
network-level context revealed an upregulation of several major
metabolic pathways in b-glucan-trainedmacrophages, including
glycolysis, pentose phosphate pathway (PPP), and cholesterol
metabolism (Figures 1C and S1). Interestingly, several important
TCA metabolites were strongly increased, such as succinate,
malate, and fumarate, as well as 2-hydroxyglutarate, leading
us to hypothesize that TCA metabolites were being replenished
through glutaminolysis (Figures 1C and S1).
Glycolysis, but Not PPP, Is an Essential Metabolic
Pathway in Trained Immunity
Glucose consumption is increased in b-glucan-trained macro-
phages (Cheng et al., 2014), and our metabolome analysis sup-
ports an increase in glycolysis. To obtain further insight into the
major accumulated products of glucose metabolism, we per-
formed NMR experiments with 13C-labeled glucose in trained
monocytes. First, glucose was converted into lactate, validating
the upregulation of glycolysis with concomitant lactate produc-
tion in b-glucan-trained monocytes that we reported previously
(Cheng et al., 2014). In addition, labeled purines were also de-
tected, showing the activation of the PPP (Figures 2A and S2).
In contrast, neither 13C-labeled metabolites of the TCA cycle
were detected after incubation of trained monocytes with
13C-labeled glucose, nor 3-13C lactate, indicating that the non-
oxidative branch from the PPP back to glycolysis was inactive
(Figures 2A and S2).
As glucose can be metabolized by aerobic glycolysis and
PPP, we assessed which of these pathways was important for
induction of trained immunity. Inhibition of mTOR and glycolytic
flux by rapamycin inhibited monocyte training, as previously
shown (Cheng et al., 2014), whereas inhibition of the oxidativeolism-associated genes. The rows indicate different gene transcripts, and the
Z scored and then plotted, with red indicating high RNA expression and blue
ples based on the expression of dynamic metabolic genes. RPMI (circles), LPS
(black). See also Table S1.
ta. The rows indicate different metabolites, and the columns indicate different
rdized and then averaged over all replicates. A PCA score plot of PC1 versus
ed according to the stimulus that was used, and the labels indicate time points
changes (filled circles) in cells treated with b-glucan versus LPS at day 6. The
glucan versus LPS. The complete map as created by Escher is depicted in
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effect (Figure 2B). The increase in cytokine production by
b-glucan-induced trained immunity is accompanied by epige-
netic changes, including an increase of H3K4 trimethylation
(H3K4me3) at promoter sites of inflammatory genes (Saeed
et al., 2014). Consistent with similar observations in cytokine pro-
duction, epigenetic changes in H3K4me3 induced by b-glucan at
the promoter sites of IL6 and TNFA were abolished by rapamy-
cin, but not by 6-AN (Figures 2B and S3). Thus, whereas glycol-
ysis is central for induction of trained immunity, inhibition of PPP
does not have a direct effect on increased cytokine production
by trained monocytes.
Metformin activates AMPK and inhibits mTOR activity (Fig-
ure S3) (Cheng et al., 2016). We have previously shown that inhi-
bition of themTORpathway that controls glucosemetabolism by
metformin counteracts the induction of trained immunity by
b-glucan in mice (Cheng et al., 2014). We now also show that
metformin inhibits lactate production, 5 days after b-glucan
training (Figure S3). To assess whether metformin has a similar
effect in vivo in humans, we initiated a proof-of-principle clinical
trial in which healthy volunteers received an incremental dose
of metformin for 6 days (up to 1,000 mg twice daily on day 6).
In line with the in vitro and murine experimental data, in vivo
administration of metformin in humans decreased the ex-vivo
b-glucan-induced training of circulating monocytes, which was
accompanied by a lower capacity to mount glycolysis and
release lactate (Figure 2C). When the study participants
stopped taking metformin, the capacity of monocytes to un-
dergo b-glucan training was fully restored (day 9 and 20), thereby
confirming the importance of glucose metabolism changes for
inducing trained immunity in humans (Figure 2C).
Glutamine and Cholesterol Metabolism Are Important
Metabolic Pathways in Trained Immunity
In addition to glycolysis and PPP, glutaminemetabolism, choles-
terol, and fatty acid synthesis pathways were also upregulated
after b-glucan training. Glutamine metabolism has been shown
to play an important role in immune activation (Li et al., 2007;
Roth, 2008; Sikalidis, 2015). Incubation of trained monocytes
with 13C-labeled glutamine resulted in increased production
of glutamate, a substrate that can replenish the TCA cycle
(Figures 3A and S2). Although no labeled succinate, fumarate,
or malate were identified due to their relatively low concentra-
tions and the limited sensitivity of the assay, we were able to
measure increases in these TCA cycle metabolites using clas-
sical biochemical methods (Figures S1 and S4). Interestingly,
no labeled lactate was detected, suggesting that glutamine is
not a source of pyruvate for lactic fermentation (Figures 3A andFigure 2. Glucose Metabolism in Trained Immunity
(A) Accumulation of the 13C label that was incorporated in 2-13C labeled glucose w
therefore showing to which products glucose is metabolized. The arrows in gray a
as means ± SEM, n = 2.
(B) Human monocytes were trained with b-glucan or left in culture medium for 24
(6-AN). After 6 days, DNA was isolated for epigenetic analysis or cells were restim
are shown as means ± SEM, n = 5, *p < 0.05, **p < 0.01, and Wilcoxon signed-r
(C) Healthy human volunteers received a twice-daily increasing dose (1–2 g) ofmet
b-glucan; after 5 days of rest, cells were restimulated with P3C and cytokine prod
and lactate production, see Figure S3. The data are shown as means ± SEM, n =S2). This interpretation was supported by the near 1:2molar ratio
of glucose:lactate observed in the 13C-glucose experiment,
suggesting that glucose is the sole source of lactate; the ratio
would have been lower if also other sources of lactate would
have been used.
Aspartic acid was also consumed in large amounts from the
medium, indicating that metabolism of amino acids other than
glutamine may also be involved in trained immunity (Figure S4).
In linewith this notion, production of 2-hydroxyglurate from a-ke-
toglutarate was also significantly increased, just as methionine
(Figure S1). Finally, in addition to the well-known pathway in
which glutamate enters the TCA cycle via a-ketoglutarate, gluta-
mate catabolism also enters the TCA cycle via succinate semial-
dehyde metabolism (Figure 1C).
In an additional set of experiments, we sought to establish the
role of glutamine, fatty acid, and cholesterol synthesis in trained
immunity by adding inhibitors of these pathways (BPTES, cerule-
nin, and fluvastatin, respectively) to the in vitro trained immunity
model. Inhibition of glutaminolysis or cholesterol synthesis in-
hibited trained immunity, whereas blockade of fatty acid synthe-
sis had no effect (Figures 3B and S3). In line with these results,
H3K4me3 was downregulated by inhibition of either glutaminoly-
sis or cholesterol synthesis (Figure 3B). We next tested the rele-
vance of these pathways in an in vivo model of trained immunity
by assessing the effects of BPTES that inhibits glutaminolysis,
and atorvastatin, which inhibit the rate-limiting enzyme in choles-
terol syntheses HMG-CoA-reductase. Mice were treated with
1 mg of b-glucan or vehicle control intraperitoneally, followed
1week later byan injectionof 10mgLPS.At 4hr after theLPSchal-
lenge, induction of cytokine synthesis wasmeasured by ELISA in
the circulating blood. We found that LPS induced a significantly
higher IL-1b concentration in plasma of b-glucan-trained mice
than of controls (Figure 3C), as previously reported (Quintin
et al., 2012). Importantly, when glutaminolysis was inhibited by
BPTES or cholesterol synthesis was inhibited by atorvastatin,
trained immunity, measured by IL-1b production, was signifi-
cantly downregulated (Figure 3C). The plasma concentrations
of TNF at this time point after LPS injection were low and not
different between the various conditions. Together, these data
show that glutaminolysis and the cholesterol synthesis pathway
are two metabolic pathways that, in addition to glycolysis, are
essential for the increased cytokine production and epigenetic
changes observed in b-glucan-induced trained immunity.
Fumarate Induces Epigenetic Changes and Trained
Immunity
Analysis of the metabolome of trained monocytes showed that
succinate, fumarate, and malate were strongly induced in theseas determined in lysates from b-glucan versus non-trainedmonocytes by NMR,
re not active. HSQC-NMR spectra are shown in Figure S2. The data are shown
hr in the presence or absence of mTOR inhibitor (rapamycin) or PPP inhibitor
ulated with LPS to determine cytokine production. See also Figure S3. The data
ank test.
formin for 6 days. At indicated time points, monocytes were trained ex vivowith
uction was assessed. For the effect of metfomin on the AMPK-mTOR pathway
11, *p < 0.05, and Wilcoxon signed-rank test.
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Training of monocytes with fumarate on day 0 dose-dependently
induced increased cytokine production upon restimulation
on day 6, whereas malate and succinate did not induce this
effect (Figure 4A). Inhibition of glycolysis or glutaminolysis by
rapamycin or BPTES, respectively, both pathways that inhibit
b-glucan-induced trained immunity, also decreased fumarate
concentrations in trained monocytes (Figure 4B). In addition,
fumarate induced H3K4me3 at the promoters of proinflamma-
tory cytokines, as observed during induction of trained immunity
by b-glucan (Figure 4C). Considering these effects, we per-
formed a whole-genome assessment of the histone marks
H3K4me3 and H3K27ac by chromatin immunoprecipitation
(ChIP)-sequencing in fumarate and b-glucan-trained monocytes
(Figure 4D). In total, 124 dynamic H3K4me3 regions (Figure 4E)
and 332 dynamic H3K27ac regions (Figure 4F) were identified
in fumarate-trained macrophages, with a log2 fold change >2.5
compared to non-trained macrophages (RPMI). By the same
criteria, b-glucan exposure induced 2,688 dynamic H3K27ac
changes (Figure S5), indicating that fumarate-induced chromatin
remodeling recapitulates only a small fraction of the total trained
epigenome. However, 95% of the genomic regions differentially
regulated by fumarate were also differentially regulated by
b-glucan (>1 log2 fold change). If for b-glucan a log2 fold change
of >2 were being used, this would account for 63% of the re-
gions. Genes associated with fumarate dynamic epigenetic re-
gions were enriched in pathways involved in immune response
and leukocytemigration (Figures 4E and 4F), consistent with pre-
vious reports in b-glucan-trainedmonocytes (Quintin et al., 2012;
Saeed et al., 2014).
Citric acid cycle metabolites (e.g., fumarate and succinate)
have previously been reported to regulate HIF1a stabilization
by inhibiting hydroxylation and therefore stabilizing HIF1a (Koi-
vunen et al., 2007; Tannahill et al., 2013). We first assessed
whether fumarate inhibited HIF1a hydroxylation in our in vitro
model. Incubation of humanmonocytes with fumarate for 2 hr in-
hibited HIF1a hydroxylation (Figure 5A), and HIF1a targets (Ke
and Costa, 2006) were induced on a transcriptional level (Fig-
ure 5B). This provides a first mechanism of how fumarate could
induce the observed phenotypical changes, but it does not
explain the observed effects on histone modifications.
Therefore, given our finding that fumarate induces H3K4me3,
we investigated whether it could induce transcription of
methyltransferases. However, none of the detectable methyl-
transferases were differentially expressed between trained and
non-trained samples (Figure S6). We therefore assessed
whether the activity of the KDM5 family of histone demethylases,
which are responsible for demethylation of H3K4 (Secombe andFigure 3. Other Metabolic Pathways in Trained Immunity
(A) Accumulation of the 13C label that was incorporated in 2-13C labeled glutamin
trained monocytes by NMR, therefore showing to which products glutamine is m
(B) Human monocytes were trained with b-glucan or left in culture medium for
synthesis inhibitor (cerulenin), or HMG-CoA reductase inhibitor (fluvastatin). After
LPS to determine cytokine production. See also Figure S3. The data are shown
(C) Mice were intraperitoneally trained with b-glucan or PBS in the presence or ab
After 7 days, an intraperitoneal LPS challenge was performed and IL-1b productio
trained mice to non-trained mice is shown. The data are shown as means ± SEMEisenman, 2007), was different in b-glucan trained macro-
phages. As shown in Figure 5C, b-glucan training of monocytes
resulted in decreased biological activity of KDM5 demethylases
on day 6 after training, which corresponds to the time point with
the highest intracellular fumarate concentrations (Figure S1), an
effect that was not observed in LPS-induced immunotolerant
macrophages (Figure 5C). Interestingly, a similar effect was
observed at transcription level (Figure S6). We also assessed
expression of KDM3a/JMJD1a (a H3K9 demethylase) and
KDM6b/JMJD3 (a H3K27 demethylase), but these genes were
not significantly influenced during induction of training (Fig-
ure S6). Finally, as a-ketoglutarate is a known cofactor for lysine
demethylases, whereas metabolites that have a comparable
molecular structure to a-ketoglutarate (e.g., fumarate or succi-
nate) are natural antagonists (Lu et al., 2012), we also determined
whether the effect of fumarate on KDM5 activity is influenced by
a-ketogluterate. KDM5 activity was significantly inhibited by
fumarate and that was restored by the addition of a-ketogluta-
rate (Figure 5D). Also at the level of cytokine production, a-keto-
glutarate was able to partially counteract the training effect of
fumarate (Figure 5E).
DISCUSSION
In this study, we provide the first mechanism linking stimulation
of innate immune pathways with the induction of epigenetic and
metabolic changes in trained immune cells. We show that
training of monocytes with b-glucan induces a rewiring of cellular
metabolism that modulates the epigenetic programming of
metabolic genes. Glycolysis, glutaminolysis, and cholesterol
synthesis are non-redundant metabolic pathways important for
trained immunity in monocytes and macrophages. Among the
detailed metabolite changes, we identify fumarate as a key
metabolite that induces trained immunity (innate immune mem-
ory), an effect mediated at least partially by induction of histone
modifications such as H3K4me3 and H3K27Ac.
The role of cellular metabolites acting as cofactors for epige-
netic enzymes has only recently been revealed in several cell
types and tissues (Donohoe and Bultman, 2012; Keating and
El-Osta, 2015). By assessing the interaction between transcrip-
tional and metabolic profiles, we identified several major meta-
bolic pathways specifically activated in trained monocytes,
compared with naive and tolerant cells. Glucose enters both
glycolysis and PPP during activation of trained monocytes.
Whereas glycolysis has been previously reported to be important
for trained immunity (Cheng et al., 2014), very little is known
regarding the role of the PPP in this process. Here, we validate
several previous studies of the role of the mTOR pathway and
glycolysis and extend them in a proof-of-principle clinical trial.e was determined in supernatants and cell lysates from b-glucan versus non-
etabolized. HSQC-NMR spectra can be found in Figure S2.
24 hr in the presence or absence of glutaminase inhibitor (BPTES), fatty acid
6 days, DNAwas isolated for epigenetic analysis or cells were restimulated with
as means ± SEM, n = 5, *p < 0.05, **p < 0.01, and Wilcoxon signed-rank test.
sence of glutamine (BPTES) or cholesterol (atorvastatin) metabolism inhibitors.
n was assessed 3 hr later. The fold of increase of IL-1b production of b-glucan
, n = 4, *p < 0.05, and paired t test.
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Figure 4. Fumarate-Induced Trained Immunity
(A) Humanmonocytes were stimulated for 24 hr with different concentrations of methyl-fumarate. At day 6, cells were restimulated for 24 hr with LPS and cytokine
production was assessed. The data are shown as means ± SEM, n = 8, *p < 0.05, one-way ANOVA, and Dunnett’s post test.
(B) Humanmonocytes were trainedwith b-glucan in the presence or absence ofmetabolic inhibitors for 24 hr. On day 6, cells were lysed and intracellular fumarate
concentrations were determined. The data are shown as means ± SEM, n = 9, *p < 0.05, **p < 0.01, and one-way ANOVA.
(C) Humanmonocytes were stimulated for 24 hr with 50 mMmethyl-fumarate. At day 6, cells were fixed, chromatin was isolated, andH3K4me3 at the promoters of
TNFA and IL6 were determined. The data are shown as means ± SEM, n = 5, *p < 0.05, and Wilcoxon signed-rank test.
(D) Experimental setup for the generation of fumarate-treated macrophages for epigenomic analysis.
(legend continued on next page)
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AC D E
B Figure 5. Fumarate Modulates HIF1a
Degradation and Epigenetic Modulators
(A) Humanmonocytes were stimulated for 2 hr with
50 mM fumarate, after which cells were lysed and
HIF1a hydroxylation was assessed by western
blot. The representative example of five experi-
ments is shown.
(B) Human monocytes were stimulated for 24 hr
with 50 mM fumarate, then mRNA was isolated and
expression of Hif1a targets was determined. The
data are shown as means ± SEM, n = 8, *p < 0.05,
and Wilcoxon signed-rank test.
(C) Human monocytes were trained with b-glucan
or tolerized with LPS for 24 hr. At day 6, nuclear
extracts were isolated and KDM5 activity was
determined. The data are shown as means + SEM,
n = 6, *p < 0.05, one-way ANOVA, and Dunnett’s
post test.
(D) Human monocytes were incubated for 24 hr
with fumarate or/and a-ketoglutarate after which
nuclear extracts were isolated and KDM5 activity
was determined. The data are shown as means +
SEM, n = 6, *p < 0.05, one-way ANOVA, and
Dunnett’s post test.
(E) Humanmonocytes were incubated for 24 hr with fumarate or/and a-ketoglutarate. At day 6, cells were restimulated for 24 hr with LPS and cytokine production
was assessed. The data are shown as means + SEM, n = 6, *p < 0.05, one-way ANOVA, and Dunnett’s post test.
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Trained Immunity, Cell Metabolism (2016), http://dx.doi.org/10.1016/j.cmet.2016.10.008By using metformin, an activator of AMP kinase and thus inhibi-
tor of mTOR, in healthy volunteers, we demonstrate a role for the
mTOR pathway in trained immunity in humans. This observation
goes beyond answering a biological question, as metformin is a
widely used drug in patients with type 2 diabetes (Singh, 2014).
Indeed, its inhibition of trained immunity might have undesired
consequences on antimicrobial host defense; on the other
hand, it may represent a potential new drug to be employed in
certain inflammatory diseases with excessive inflammation (Ro-
bey et al., 2015; Singhal et al., 2014; Tan et al., 2015). In contrast
to glycolysis, the oxidative branch of PPP does not seem to have
a major impact on trained immunity.
Using a systems biology approach, our analysis of intracellular
metabolites of trained monocytes identified additional pathways
that are involved in trained immunity (Figure 6). The metabolism
of several amino acids was enhanced, including glutamine.
Metabolism of glutamine into glutamate, a-ketoglutarate, and
succinate semialdehyde provides substrates for the TCA cycle
such as fumarate and succinate. Interestingly, fumarate itself
induces trained immunity as well. Trained immunity induced
by fumarate results in increased trimethylation of histones at
H3K4, and interestingly also acetylation at H3K27, linking immu-
nometabolic activation with long-term epigenetic changes.
Importantly, the epigenetic program induced by fumarate
partially reproduces that of b-glucan-induced training, demon-
strating its likely involvement in mediating at least part of the
effects of b-glucan.
KDMs of the JmjC and JmjD family need a-ketoglutarate as a
cofactor for the demethylation process (Lu et al., 2012), whereas(E) Heatmap of H3K4me3 reads (purple) over fumarate-specific peaks. The inten
fumarate-Mf, with each row (x axis) corresponding to a peak.
(F) Heatmap of H3K27ac reads (red) over fumarate-specific peaks. The intensi
fumarate-Mf. The top GO pathways (from DAVID) associated with the nearest gen
also Figure S5.metabolites with a similar molecular structure, such as fumarate,
can act as antagonizing factors (Lu et al., 2012; Xiao et al., 2012),
thereby inhibiting demethylation. The KDM5 family of demethy-
lases (that is responsible for H3K4 demethylation) has been
shown to be inhibited by fumarate (Lu et al., 2012; Xiao et al.,
2012). Recently, locally produced fumarate has also been shown
to play a role in DNA repair by inhibition of KDM2B histone deme-
thylase activity, which resulted in enhanced H3K36me2 (Jiang
et al., 2015). We now show that fumarate inhibits the bioactivity
of KDM5s in our model of trained immunity and that a-ketogluta-
rate can counteract this effect. In addition to fumarate, the con-
centration of 2-hydroxyglutarate, which has similar antagonizing
effects on a-ketoglutarate-dependent demethylases (Yang et al.,
2012), is greatly increased in b-glucan-trained macrophages too
(Figure S1). Therefore, 2-hydroxyglutarate may serve as another
essential factor in modulating histone marks in trained immunity
induced by b-glucan. Xiao et al. (2012) have previously shown
that fumarate (and potentially 2-hydroxyglutarate) does not
only affect histone demethylases, but also affect DNA demethy-
lases. The effect of b-glucan training and metabolic alterations
on DNA methylation is therefore an intriguing topic for future
research. In addition to the effects of fumarate on epigenetic
enzymes, fumarate also inhibits proteasomal degradation of
HIF1a, an essential transcription factor in b-glucan-induced
trained immunity (Cheng et al., 2014; Koivunen et al., 2007;
Serra-Pe´rez et al., 2010). In this process, a-ketoglutarate is a
cofactor for the hydroxylation necessary for HIF1a degradation;
fumarate is a natural antagonist of this reaction, thereby stabiliz-
ing HIF1a.sity over the center of the peak ±12 kb is depicted for RPMI-Mf, BG-Mf, and
ty over the center of the peak ±12 kb is depicted for RPMI-Mf, BG-Mf, and
es to dynamic H3K4me3 and H3K27ac are shown, with adjusted p values. See
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Figure 6. Overview Figure Showing the
Metabolic and Epigenetic Pathways through
which b-glucan Induces Trained Immunity
Training of monocytes by b-glucan induces com-
plex metabolic pathways: while glycolysis, gluta-
minolysis, and cholesterol synthesis are important
for induction of trained immunity, the PPP and fatty
acid synthesis have no direct effect. Fumarate
accumulation through glutaminolysis has a central
role for induction of histone modifications and in-
duction of trained immunity.
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nity in monocytes induces profound changes in cellular meta-
bolism. The three most prominent metabolic pathways involved
in trained immunity are glycolysis, glutaminolysis, and choles-
terol synthesis, which are linked to enrichment in H3K4me3
that is essential for trained immunity by b-glucan. Finally, we
provide proof-of-principle of metabolo-epigenomic circuits in
innate immune memory by demonstrating an essential role for
fumarate in modulating HIF1a degradation, histone methylation,
and acetylation. The identification of the metabolic pathways
contributing to induction of trained immunity improves under-
standing of innate immune memory and opens new therapeutic
avenues.
EXPERIMENTAL PROCEDURES
Peripheral Blood Mononuclear Cell and Monocyte Isolation
Buffy coats from healthy donors were obtained after written informed consent
(Sanquin Blood Bank, Nijmegen, the Netherlands). Peripheral blood mononu-
clear cell (PBMC) isolation was performed by dilution of blood in pyrogen-free
PBS and differential density centrifugation over Ficoll-Paque (GE Healthcare).
Cells were washed twice in PBS. Training of adherent monocytes was per-
formed as previously described (Quintin et al., 2012); see also below. Percoll
isolation of monocytes was performed as previously described (Repnik
et al., 2003). Briefly, 150  200 3 106 PBMCs were layered on top of a
hyper-osmotic Percoll solution (48.5% Percoll [Sigma-Aldrich], 41.5% sterile
H2O, and 0.16 M filter-sterilized NaCl) and centrifuged for 15 min at 580 3 g.
The interphase layer was isolated and cells were washed with cold PBS. Cells
were resuspended in RPMI culturemedium (RPMImedium, Invitrogen) supple-
mented with 10 mg/mL gentamicin, 10 mM Glutamax, and 10 mM pyruvate,
and counted. An extra purification step was added by adhering Percoll-iso-
lated monocytes to polystyrene flat bottom plates (Corning) for 1 hr at 37C;
a washing step with warm PBS was then performed to yield maximal purity.
Monocyte Training and Inhibition Experiments
100 mL cells were added to flat bottom 96-well plates. After washing with
warm PBS, monocytes were incubated with culture medium only as a nega-
tive control or 5 mg/mL of b-glucan, (b-1,3-(D)-glucan, kindly provided by
Professor David Williams), 100 mMmono methyl-fumarate, or dimethyl-2-oxo-
glutarate (Sigma) for 24 hr (in 10% pooled human serum). Cells were washed10 Cell Metabolism 24, 1–13, December 13, 2016once with 200 mL warm PBS and incubated for
5 days in culture medium with 10% serum and me-
dium was changed once. Cells were restimulated
with 200 mL RPMI, Escherichia coli LPS (serotype
055:B5, Sigma-Aldrich, 10 ng/mL), or Pam3Cys
(EMC Microcollections, L2000, 10 mg/mL). After
24 hr, supernatants were collected and stored
at 20C (see Figure S1). In some experiments,
cells were preincubated (before b-glucan training)
for 1 hr with 10 nM rapamycin (Sigma), 50 mM
BPTES (Sigma), 2 mg/mL Ceruline (Sigma),100 mM 6-aminonicotinamide (Sigma), and 20 mM fluvastatin sodium hydrate
(Sigma). Concentrations were selected as being the highest non-cytotoxic
concentrations.
Cytokine and Lactate Measurements
Cytokine production was determined in supernatants using commercial ELISA
kits for TNF-a (R&D Systems) and IL-6 (Sanquin) following the instructions of
the manufacturer. Lactate concentration was measured using a Lactate Fluo-
rometric Assay Kit (BioVision).
High-Performance Liquid Chromatography and NMR
Amino acids were quantified by high-performance liquid chromatography
(HPLC) in a Gilson UV/vis_155 detector (338 nm) after precolumn derivatization
with ortho-phthalaldehyde (OPA with methanol R99.9%, potassium borate
1 M pH = 9.5 and 2-mercaptoethanol R99.0%) 1:5 (Sigma-Aldrich). Culture
supernatants were filtered by Acrodisc 13 mm syringe filters with 0.2 mm
supor membrane (Pall). Inorganic mobile phase pH = 7.8 was composed by
Na2HPO4.2H2O3 50 mM: propionic acid 250 mM (1:1) mixture (Merck) with
acetonitrile HPLC grade in water (10:2:13). Organic mobile phase was
composed by acetonitrile, methanol, andwater (3:3:4) (HPLC grade, HiPerSolv
Chromanorm, VWR Chemicals). All mobile phases for elution were degasified
for 30 min previously to analysis. Amino acids were quantified using the Gilson
Uniprot Software, version 5.11 accordingly to standard solutions were pre-
pared in MilliQ water (Millipore).
For NMR spectroscopy, methanol/water extracts and cell culture superna-
tants were analyzed. The aqueous and chloroform extracts were dried in a
SpeedVac Plus system. The aqueous extract was suspended in 600 mL D2O
with 0.262 mM of TSP-d4 as chemical shift indicator and the organic extract
in 600 mL CD3Cl. To 550 mL of cell culture media were added 50 mL D2O,
with a TSP-d4 final concentration of 0.262 mM.
The samples were analyzed at 25C by 1H-NMR and by 2D 13C-1H- hetero-
nuclear single quantum coherence (HSQC) spectroscopy in a UltrashiedTM
800 Plus (Bruker) operating at 800.33 MHz, equipped with a TXI-Z H C/N/-D
(5 mm) probe. The 1H-NMR pulse sequence used has a NOESY-presaturation
(noesygppr1d) with irradiation at the water frequency (ns 124, TD 64K, SW
20 ppm, d1 4 s, d8 0.01 s); while in the 13C-1H-HSQC was used the
hsqcetgpsisp2 pulse sequence (ns 16, TD1 512, TD2 2K, SW2 16 ppm, SW1
165 ppm, d1 1 s). The chemical shifts in aqueous sample were referred to
TSP, while the samples in chloroform-d were referred to the solvent signal.
Spectra were acquired and processed using TopSpin 3.2 software (Bruker);
assignments were made by comparison with chemical shifts found in the
literature for metabolic intermediates and Human Metabolome Database
(http://www.hmdb.ca). The quantifications of the signals were performed by
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Metabolite Measurements
Cells were cultured as described above. At day 6, cells were detached from the
plate with Versene (Life Technologies) and counted. At least one million cells
were lysed in 60 mL 0.5% Triton-X in PBS. Metabolite concentrations were
determined by commercial assay kits for Acetyl CoA, fumarate, glutamate,
malate, NADPH, a-ketoglutarate (all Sigma), following the instructions of the
manufacturer.
mRNA Extraction and RT-PCR
Cells were cultured as described above, after 4 hr, 12 hr, and 24 hr for fumarate
stimulation or after 6 days after b-glucan training mRNA was extracted by
TRIzol (Life Technologies), according to the manufacturer’s instruction, and
cDNA was synthesized using iScript reverse transcriptase (Invitrogen). Rela-
tive mRNA levels were determined using the Applied Biosciences StepOne
PLUS and the SYBR Green method (Invitrogen). Values are expressed as
fold increases in mRNA levels, relative to those in non-trained cells, with
b-2-microglobulin or HPRT as housekeeping genes. Primers are listed in Table
S4. RNA-sequencing was performed as described before (Saeed et al., 2014)
(GEO: GSE86940 and GSE85246).
Chromatin Immunoprecipitation
10 3 106 monocytes were trained in vitro in 10 cm petri dishes (Greiner) in
10 mL medium volumes. Cells were isolated and trained as described above.
After resting for 5 days in culture medium, the cells were detached from the
plate with Versene and fixed in methanol-free 1% formaldehyde. Cells were
then sonicated and immunoprecipitation was performed using antibodies
against H3K4me3 (Diagenode). After ChIP, DNA was processed further for
qPCR analysis using SYBR green. Samples were analyzed by a comparative
Ct method in which myoglobin was used as a negative control and H2B as a
positive control according to the manufacturer’s instructions. Primers are
listed in Table S4. ChIP sequencing was performed as described before
(Saeed et al., 2014).
Metabolome Assessment
Cells were cultured as described above. At 0 hr, 4 hr, 24 hr, and 6 days, cells
were harvested and cell pellets were snap frozen and stored at 80C until
metabolite analysis. Measurement of metabolites was performed by liquid
chromatography-tandem mass spectrometry (LC-MS). Polar metabolites
were extracted in 80% methanol. Metabolic profiles were obtained using
three LC-MS methods. Two separate hydrophilic interaction liquid chroma-
tography (HILIC) methods were used to measure polar metabolites in posi-
tive and negative ionization mode MS, and one reversed phase method
was used to profile lipids in the positive ion mode. Polar metabolites were
profiled in the positive ion MS mode using an LC system comprising a
1200 Series Pump (Agilent Technologies) and an HTS PAL Autosampler
(Leap Technologies) that was coupled to a 4000 QTRAP mass spectrometer
(AB SCIEX) equipped with an electrospray ionization source. Samples were
prepared by drying 100 mL of cell extracts under nitrogen and resuspend-
ing the residue in 100 mL of 10/67.4/22.4/0.2 v/v/v/v water/acetonitrile/
methanol/formic acid containing stable-isotope labeled internal standards
(valine-d8, Sigma-Aldrich; and phenylalanine-d8, Cambridge Isotope Labora-
tories). The samples were centrifuged (10 min, 1,610 3 g, 4 mC), and the
supernatants were injected directly onto a 150 mm 32.1 mm Atlantis HILIC
column (Waters). The column was eluted isocratically with 5% mobile pha-
seA (10 mM ammonium formate/0.1% formic acid) for 1 min followed by a
linear gradient to 40% mobile phase B (acetonitrile/0.1% formic acid) over
10 min. The ion spray voltage was 4.5 kV and the source temperature was
425 mC. All metabolites were measured using several reaction monitoring
scans (MRM). MS settings, including declustering potentials and collision en-
ergies, for each metabolite were optimized by infusion of reference stan-
dards before sample analyses.
MultiQuant software (version 1.2; AB SCIEX) was used to process all raw LC-
MS data and integrate chromatographic peaks. The processed data were
manually reviewed for quality of integration and compared against known
standards to confirm metabolite identities.Metabolomics Preprocessing
Missing Values
If no peak was detected for a certain metabolite in a particular sample, its con-
centration was assumed to be below the detection limit. A value of half themin-
imum value of that metabolite over all samples was used for thesemetabolites.
In doing this, we assume that the minimum value found for a particular metab-
olite is close to the detection limit.
Data Scaling
The metabolomics data were log2 transformed before most of the analyses
were performed (exceptions are mentioned in the next sections). Depending
on the type of analysis, different additional scaling steps were performed.
Metformin Proof-of-Principle Trial
The oral metformin study was performed in 12 healthy volunteers, all of whom
providedwritten informed consent. Exclusion criteria consisted of obesity, kid-
ney failure, or metabolic disorders. Volunteers received increasing dosages of
metformin for a total of 5 days (500 mg on day 1 and 2,000 mg on day 6). Blood
sampling was performed 1 day before start of metformin (day 0), during met-
formin intake (day 6), on day 9, and on day 20. The study was approved by
the local institutional review board (Arnhem-Nijmegen Medical Ethical Com-
mittee) and conducted according to the principles of the International Confer-
ence on Harmonization-Good Clinical Practice guidelines.
Animal Experiments
C57BL/6J mice were trained by intraperitoneal injection with 1 mg b-glucan as
previously described (Quintin et al., 2012). At 1 hr before and 2 hr after intraper-
itoneal injection of b-glucan or PBS, mice received an intraperitoneal injection
of PBS, 200 mg BPTES, or 125 mg atorvastatine. After 7 days, mice were chal-
lenged with 10 mg LPS intraperitoneally; after 3 hr, mice were sacrificed and
circulating IL-1m and TNF concentrations were measured by ELISA (R&D Sys-
tems) according to the manufacturer’s instructions. The study was approved
by the ethical animal committee of the University of Colorado, Denver.
KDM5 Activity Assay
Nuclear extracts were prepared according to the method of Schreiber et al.
(1990). Cells were cultured as described above, 24 hr for fumarate or a-keto-
glutarate stimulation and 5 days after 24 hr stimulation with b-glucan or LPS in
10 cm petri dishes. 1 3 106 cell were resuspended in 400 ml cell lysis buffer
(10 mM HEPES; pH 7.5, 10 mM KCl, 0.1 mM EDTA, 1 mM DTT, 0.5% Noni-
det-40, and 0.5 mM PMSF along with the protease inhibitor cocktail [Sigma])
and allowed to swell on ice for 20min with intermittent mixing. Tubes were vor-
texed and then centrifuged at 12,0003 g at 4C for 10 min. The pelleted nuclei
were washed twice with the cell lysis buffer and resuspended in 25 mL ice-cold
nuclear extraction buffer (20 mM HEPES [pH 7.5], 400 mM NaCl, 1 mM EDTA,
1 mM DTT, and 1 mM PMSF with protease inhibitor cocktail) and incubated in
ice for 30 min with intermitted sonication. Nuclear extract was collected by
centrifugation at 12,000 3 g for 15 min at 4C. The supernatant was used
immediately in a fluorometric KDM5/JARID Activity Quantification Assay Kit
(Abcam), performed following the instructions of the company.
Analysis Methods
Principal Component Analysis
In the principal component analysis (PCA) of the metabolomics data, the data
were first mean-centered. PCA was performed using the function ‘‘prcomp’’
from the ‘‘stats’’ package, part of the ‘‘R’’ language.
Univariate Statistical Testing
For the univariate statistical tests, no further scaling was performed. p values
were calculated using a two-sided paired t test, using the function ‘‘t.test,’’ part
of the ‘‘R’’ language. p values were corrected using the Benjamini-Hochberg
false discovery rate procedure (as implemented in R). Pathway enrichment
analysis: Pathway enrichment analysis was performed using two different
methods. The first was ‘‘Pathway-tools’’ (Chen et al., 2014), the stand-alone
version of the tool integrated into the Biocyc online resource (Caspi et al.,
2014). This tool allows additional visualization of the data on a metabolic
pathway map (both metabolomic and transcriptomic), but this tool does not
allow the definition of a background metabolic set (all metabolites measured
by the used platform). Pathway-tools require the definition of a set of signifi-
cantly differentially expressed metabolites/genes. Metabolites and genesCell Metabolism 24, 1–13, December 13, 2016 11
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FDR <0.1. The second method used to perform pathway-enrichment analysis
is ‘‘MetaboAnalyst’’ (Xia et al., 2015), which does allow the definition of such a
background set. MetaboAnalyst additionally has the advantage of performing
a quantitative enrichment analysis instead of using a hard threshold, however,
it does not allow the type of visualization that is provided by Pathway-tools.
This complementary set of options was the reason for using both tools.
A quantitative enrichment analysis was performed using the peak intensities
as an input (before log2 transform). The settings were as follows: missing
values were imputed as explained in Metabolomics Preprocessing and no
data filtering or scaling was applied. The pathway-associated metabolite
sets were used to check for enrichment (before and after log transformation),
using all metabolitesmeasuredwithmass spectrometry as a custom reference
set. Pathways of less than four compounds were filtered from our analysis.
p values for enriched pathways in both methods were corrected using the
Benjamini-Hochberg false discovery rate procedure.
Data Visualization
The first explorative visualization was performed using Pathway-tools, which
allows visualization of both transcriptomic and metabolomic data. Based on
the pathways that were significantly differentially expressed in either the me-
tabolomic or transcriptomic data, the interesting parts of the map were
explored. Next, using the tool ‘‘Escher’’ (King et al., 2015), a pathway map
was created, containing just the parts found to be of interest. A schematic
overview of the pathways is depicted in Figure 1C (the complete map as
created by Escher is depicted in Figure S1).
Statistics
Ex vivo and in vitro monocyte experiments were analyzed using a Wilcoxon
signed-rank test or one-way ANOVA, where applicable. A p value below
0.05 was considered statistically significant. These data were analyzed
using GraphPad Prism 5.0. *p < 0.05 and **p < 0.01. Data are shown as
means ± SEM.
ACCESSION NUMBERS
The accession numbers for the RNA sequencing time course of control,
b-glucan-trained, and LPS-immunotolerant monocytes and RNA sequencing
and ChIP sequencing data of control and fumarate- and b-glucan-trained
monocytes at day 6 reported in this paper are GEO: GSE85246 and
GSE86940.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2016.10.008.
AUTHOR CONTRIBUTIONS
Conceptualization: R.J.W.A., B.N., R.t.H., S.-C.C., F.L.v.d.V., J.W.M.v.d.M.,
C.A.D., L.A.B.J., and M.G.N.; Formal Analysis and Investigation: R.J.W.A.,
B.N., R.t.H., S.B., E.L., F.R., R.S., S.-C.C., S.-Y.W., E.H., L.G.G., I.M., C. Cu-
nha, A.v.L., and C. Clish; Resources: D.L.W. and L.A.B.J.; Writing - Original
Draft: R.J.W.A., B.N., and M.G.N.; Writing - Review & Editing: A.C.,
F.L.v.d.V., L.A.O.N., N.P.R., R.v.C., R.A.N., H.G.S., R.J.X., and M.G.N.; and
Supervision: A.C., C.L., N.P.R., R.v.C., C. Clish, R.A.N., L.A.B.J., H.G.S.,
and M.G.N.
ACKNOWLEDGMENTS
M.G.N. is supported by an ERC Consolidator grant (310372) and a Spinoza
grant of the Netherlands Organization for Scientific Research (NWO). B.N. is
supported by an NHMRC (Australia) CJ Martin Early Career Fellowship.
N.P.R. is supported by a Dr. Dekker grant (2012T051) from the Netherlands
Heart Foundation (2012T051). N.P.R. and M.G.N. received a H2020 grant
(H2020-PHC-2015-667873-2) from the European Union (grant agreement
667837). A.C., R.S., L.G.G., and C. Cunha were supported by the Fundac¸a˜o12 Cell Metabolism 24, 1–13, December 13, 2016para a Cieˆncia e Tecnologia, FCT (IF/00735/2014 to A.C., IF/00021/2014 to
R.S., RECI/BBB-BQB/0230/2012 to L.G.G., and SFRH/BPD/96176/2013 to
C. Cunha). The NMR spectrometers are part of the National NMR Facility
supported by FCT (RECI/BBB-BQB/0230/2012). The research leading to these
results received funding from the Fundac¸a˜o para a Cieˆncia e Tecnologia (FCT),
cofunded by Programa Operacional Regional do Norte (ON.2—ONovo Norte);
from the Quadro de Refereˆncia Estrate´gico Nacional (QREN) through the
Fundo Europeu de Desenvolvimento Regional (FEDER) and from the Projeto
Estrate´gico – LA 26 – 2013–2014 (PEst-C/SAU/LA0026/2013). R.J.X. was
supported by NIH (DK43351 and DK097485) and Helmsley Trust. D.L.W. is
supported, in part, by the NIH (GM53522, GM083016, GM119197, and
C06RR0306551).
Received: January 16, 2016
Revised: May 23, 2016
Accepted: October 12, 2016
Published: November 17, 2016
REFERENCES
Caspi, R., Altman, T., Billington, R., Dreher, K., Foerster, H., Fulcher, C.A.,
Holland, T.A., Keseler, I.M., Kothari, A., Kubo, A., et al. (2014). The MetaCyc
database of metabolic pathways and enzymes and the BioCyc collection of
Pathway/Genome Databases. Nucleic Acids Res. 42, D459–D471.
Chen, Q., Giedt, M., Tang, L., and Harrison, D.A. (2014). Tools andmethods for
studying the Drosophila JAK/STAT pathway. Methods 68, 160–172.
Cheng, S.C., Quintin, J., Cramer, R.A., Shepardson, K.M., Saeed, S., Kumar,
V., Giamarellos-Bourboulis, E.J., Martens, J.H., Rao, N.A., Aghajanirefah, A.,
et al. (2014). mTOR- and HIF-1a-mediated aerobic glycolysis as metabolic
basis for trained immunity. Science 345, 1250684.
Cheng, S.C., Scicluna, B.P., Arts, R.J., Gresnigt, M.S., Lachmandas, E.,
Giamarellos-Bourboulis, E.J., Kox, M., Manjeri, G.R., Wagenaars, J.A.,
Cremer, O.L., et al. (2016). Broad defects in the energy metabolism of leuko-
cytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406–413.
Donohoe, D.R., and Bultman, S.J. (2012). Metaboloepigenetics: interrelation-
ships between energy metabolism and epigenetic control of gene expression.
J. Cell. Physiol. 227, 3169–3177.
Fu, Z.Q., and Dong, X. (2013). Systemic acquired resistance: turning local
infection into global defense. Annu. Rev. Plant Biol. 64, 839–863.
Hirschey, M.D., DeBerardinis, R.J., Diehl, A.M., Drew, J.E., Frezza, C., Green,
M.F., Jones, L.W., Ko, Y.H., Le, A., Lea, M.A., et al.; Target Validation Team
(2015). Dysregulated metabolism contributes to oncogenesis. Semin. Cancer
Biol. 35 (Suppl ), S129–S150.
Jiang, Y., Qian, X., Shen, J., Wang, Y., Li, X., Liu, R., Xia, Y., Chen, Q., Peng, G.,
Lin, S.Y., and Lu, Z. (2015). Local generation of fumarate promotes DNA repair
through inhibition of histone H3 demethylation. Nat. Cell Biol. 17, 1158–1168.
Ke, Q., and Costa, M. (2006). Hypoxia-inducible factor-1 (HIF-1). Mol.
Pharmacol. 70, 1469–1480.
Keating, S.T., and El-Osta, A. (2015). Epigenetics and metabolism. Circ. Res.
116, 715–736.
King, Z.A., Dr€ager, A., Ebrahim, A., Sonnenschein, N., Lewis, N.E., and
Palsson, B.O. (2015). Escher: A web application for building, sharing, and
embedding data-rich visualizations of biological pathways. PLoS Comput.
Biol. 11, e1004321.
Kleinnijenhuis, J., Quintin, J., Preijers, F., Joosten, L.A., Ifrim, D.C., Saeed, S.,
Jacobs, C., van Loenhout, J., de Jong, D., Stunnenberg, H.G., et al. (2012).
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection
from reinfection via epigenetic reprogramming of monocytes. Proc. Natl.
Acad. Sci. USA 109, 17537–17542.
Koivunen, P., Hirsil€a, M., Remes, A.M., Hassinen, I.E., Kivirikko, K.I., and
Myllyharju, J. (2007). Inhibition of hypoxia-inducible factor (HIF) hydroxylases
by citric acid cycle intermediates: possible links between cell metabolism
and stabilization of HIF. J. Biol. Chem. 282, 4524–4532.
Kurtz, J. (2005). Specific memory within innate immune systems. Trends
Immunol. 26, 186–192.
Please cite this article in press as: Arts et al., Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in
Trained Immunity, Cell Metabolism (2016), http://dx.doi.org/10.1016/j.cmet.2016.10.008Li, P., Yin, Y.L., Li, D., Kim, S.W., and Wu, G. (2007). Amino acids and immune
function. Br. J. Nutr. 98, 237–252.
Lu, C., Ward, P.S., Kapoor, G.S., Rohle, D., Turcan, S., Abdel-Wahab, O.,
Edwards, C.R., Khanin, R., Figueroa, M.E., Melnick, A., et al. (2012). IDH mu-
tation impairs histone demethylation and results in a block to cell differentia-
tion. Nature 483, 474–478.
Mills, E.L., and O’Neill, L.A. (2015). Reprogramming mitochondrial metabolism
in macrophages as an anti-inflammatory signal. Eur. J. Immunol 46, 13–21.
Muthamilarasan,M., and Prasad, M. (2013). Plant innate immunity: an updated
insight into defense mechanism. J. Biosci. 38, 433–449.
Netea, M.G., Quintin, J., and van der Meer, J.W. (2011). Trained immunity: a
memory for innate host defense. Cell Host Microbe 9, 355–361.
Netea, M.G., Joosten, L.A., Latz, E., Mills, K.H., Natoli, G., Stunnenberg, H.G.,
O’Neill, L.A., and Xavier, R.J. (2016). Trained immunity: A program of innate im-
mune memory in health and disease. Science 352, aaf1098.
O’Sullivan, T.E., Sun, J.C., and Lanier, L.L. (2015). Natural killer cell memory.
Immunity 43, 634–645.
Pearce, E.L., Poffenberger, M.C., Chang, C.H., and Jones, R.G. (2013). Fueling
immunity: insights into metabolism and lymphocyte function. Science 342,
1242454.
Quintin, J., Saeed, S., Martens, J.H., Giamarellos-Bourboulis, E.J., Ifrim, D.C.,
Logie, C., Jacobs, L., Jansen, T., Kullberg, B.J., Wijmenga, C., et al. (2012).
Candida albicans infection affords protection against reinfection via functional
reprogramming of monocytes. Cell Host Microbe 12, 223–232.
Repnik, U., Knezevic, M., and Jeras, M. (2003). Simple and cost-effective
isolation of monocytes from buffy coats. J. Immunol. Methods 278, 283–292.
Robey, R.B., Weisz, J., Kuemmerle, N.B., Salzberg, A.C., Berg, A., Brown,
D.G., Kubik, L., Palorini, R., Al-Mulla, F., Al-Temaimi, R., et al. (2015).
Metabolic reprogramming and dysregulated metabolism: cause, conse-
quence and/or enabler of environmental carcinogenesis? Carcinogenesis 36
(Suppl 1 ), S203–S231.
Roth, E. (2008). Nonnutritive effects of glutamine. J. Nutr. 138, 2025S–2031S.
Saeed, S., Quintin, J., Kerstens, H.H., Rao, N.A., Aghajanirefah, A., Matarese,
F., Cheng, S.C., Ratter, J., Berentsen, K., van der Ent, M.A., et al. (2014).
Epigenetic programming of monocyte-to-macrophage differentiation and
trained innate immunity. Science 345, 1251086.
Schreiber, E., Harshman, K., Kemler, I., Malipiero, U., Schaffner, W., and
Fontana, A. (1990). Astrocytes and glioblastoma cells express novel oc-
tamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell
type Oct-2 proteins. Nucleic Acids Res. 18, 5495–5503.Secombe, J., and Eisenman, R.N. (2007). The function and regulation of the
JARID1 family of histone H3 lysine 4 demethylases: the Myc connection.
Cell Cycle 6, 1324–1328.
Serra-Pe´rez, A., Planas, A.M., Nu´n˜ez-O’Mara, A., Berra, E., Garcı´a-Villoria, J.,
Ribes, A., and Santalucı´a, T. (2010). Extended ischemia prevents HIF1alpha
degradation at reoxygenation by impairing prolyl-hydroxylation: role of
Krebs cycle metabolites. J. Biol. Chem. 285, 18217–18224.
Shah, J., Chaturvedi, R., Chowdhury, Z., Venables, B., and Petros, R.A. (2014).
Signaling by small metabolites in systemic acquired resistance. Plant J. 79,
645–658.
Sikalidis, A.K. (2015). Amino acids and immune response: a role for cysteine,
glutamine, phenylalanine, tryptophan and arginine in T-cell function and can-
cer? Pathol. Oncol. Res. 21, 9–17.
Singh, S. (2014). Type 2 diabetes pharmacoepidemiology update 2014: safety
versus efficacy. Curr. Diab. Rep. 14, 563.
Singhal, A., Jie, L., Kumar, P., Hong, G.S., Leow, M.K., Paleja, B., Tsenova, L.,
Kurepina, N., Chen, J., Zolezzi, F., et al. (2014). Metformin as adjunct antituber-
culosis therapy. Sci. Transl. Med. 6, 263ra159.
Sun, J.C., Beilke, J.N., and Lanier, L.L. (2009). Adaptive immune features of
natural killer cells. Nature 457, 557–561.
Tan, Z., Xie, N., Cui, H., Moellering, D.R., Abraham, E., Thannickal, V.J., and
Liu, G. (2015). Pyruvate dehydrogenase kinase 1 participates in macrophage
polarization via regulating glucose metabolism. J. Immunol. 194, 6082–6089.
Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M.,
McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H.,
et al. (2013). Succinate is an inflammatory signal that induces IL-1b through
HIF-1a. Nature 496, 238–242.
Van den Bossche, J., Baardman, J., and de Winther, M.P. (2015). Metabolic
characterization of polarized M1 and M2 bone marrow-derived macrophages
using real-time extracellular flux analysis. J. Vis. Exp. http://dx.doi.org/10.
3791/53424.
Xia, J., Sinelnikov, I.V., Han, B., and Wishart, D.S. (2015). MetaboAnalyst 3.0–
making metabolomics more meaningful. Nucleic Acids Res. 43, W251–W257.
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu,
Y., et al. (2012). Inhibition of a-KG-dependent histone and DNA demethylases
by fumarate and succinate that are accumulated in mutations of FH and SDH
tumor suppressors. Genes Dev. 26, 1326–1338.
Yang, H., Ye, D., Guan, K.L., and Xiong, Y. (2012). IDH1 and IDH2 mutations in
tumorigenesis: mechanistic insights and clinical perspectives. Clin. Cancer
Res. 18, 5562–5571.Cell Metabolism 24, 1–13, December 13, 2016 13
Cell Metabolism, Volume 24Supplemental InformationGlutaminolysis and Fumarate Accumulation
Integrate Immunometabolic and Epigenetic
Programs in Trained Immunity
Rob J.W. Arts, Boris Novakovic, Rob ter Horst, Agostinho Carvalho, Siroon
Bekkering, Ekta Lachmandas, Fernando Rodrigues, Ricardo Silvestre, Shih-Chin
Cheng, Shuang-Yin Wang, Ehsan Habibi, Luís G. Gonçalves, Inês Mesquita, Cristina
Cunha, Arjan van Laarhoven, Frank L. van de Veerdonk, David L. Williams, Jos W.M.
van der Meer, Colin Logie, Luke A. O'Neill, Charles A. Dinarello, Niels P.
Riksen, Reinout van Crevel, Clary Clish, Richard A. Notebaart, Leo A.B.
Joosten, Hendrik G. Stunnenberg, Ramnik J. Xavier, and Mihai G. Netea
  
Acetyl CoA
R
P
M
I
b-
gl
uc
an
0
20
40
60
80
100
**
p
m
o
l/
1
 m
il
li
o
n
 c
e
ll
s
alpha-ketoglutarate
R
P
M
I
b-
gl
uc
an
0.0
0.5
1.0
1.5
n
m
o
l/
1
 m
il
li
o
n
 c
e
ll
s
Fumarate
R
P
M
I
b-
gl
uc
an
0
1
2
3
4 *
n
m
o
l/
1
 m
il
li
o
n
 c
e
ll
s
Malate
R
P
M
I
b-
gl
uc
an
0.0
0.5
1.0
1.5
2.0
2.5
*
R
a
ti
o
 (
m
a
la
te
/p
ro
te
in
)
Glutamate
R
P
M
I
b-
gl
uc
an
0
2
4
6
8
*
R
a
ti
o
 (
g
lu
ta
m
a
te
/p
ro
te
in
)
NADPH
R
P
M
I
b-
gl
uc
an
0
1
2
3
4 **
n
m
o
l/
1
 m
il
li
o
n
 c
e
ll
s
 
Figure S1. Related to Figure 1-5. Experimental setup. Monocytes were isolated from buffy coats and plated to flat-bottom 
plates. Cells were left to adhere for 1 h and were washed once with warm PBS to reach maximum purity. Then, depending on 
the experiment inhibitors and/or β-glucan were added. After 24h incubation, cells were washed once with warm PBS and were 
left to rest in culture medium for five days (with one medium change half way). At day six, cells were restimulated for 24h 
with RPMI of 10ng/ml LPS. The experiment was terminated at several time points as depicted. Metabolome and RNA-seq 
samples were taken directly after 4 h, 24 h and 6 days. Epigenetic analysis was always performed on day six, prior to 
restimulation. And cytokines were always determined after the whole protocol was finished.  
At day 6, cells were lysed and intracellular concentrations of metabolites were determined. Metabolites are shown as circles; 
reactions are shown as arrows. Significantly upregulated (red), downregulated (green), and unchanged (gray) 
reactions/metabolites are shown. Metabolites that were not measured are depicted as small-unfilled circles. Figure was created 
using the tool "Escher." 
  
` 
Figure S2. Related to Figure 2A and 3A. 
1
H-
13
C HSQC-NMR spectra. The destination of 
13
C labeled glucose (left) or 
glutamine (right) was determined in β-glucan vs non-trained monocytes by NMR both in cells (upper) and culture medium 
(lower panels).  
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Figure S3. Related to Figure 2&3. Human monocytes were incubated for 24h with β-glucan in the presence of absence of 
metabolic inhibitors in 10cm petri dishes. After 24h cells were washed and 10% serum in RPMI was added, on day 3 medium 
was changed. On day 6 cells were washed once with warm PBS. The adherent macrophages were deattached and 50.000 cells 
were reseeded in 96-well flat-bottom plates and stimulated with RPMI or 10ng/ml LPS for 24h and cytokine and lactate 
production were assessed. RPMI restimulated cells did not produce TNF or IL6. Metformin activates AMPK and inhibits 
mTOR. Human monocytes were incubated for 2h with 3mM of metformin, then cells were lysed and phosphorylation of ACC 
(downstream target of AMPK) and S6K (downstream target of mTOR) were assessed by Western Blotting. 
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Figure S4. Related to Figure 3. Amino acid consumption during β-glucan-induced trained immunity. Monocytes were 
trained with β-glucan for 24 h. Post-treatment amino acid concentrations in the culture medium were determined at indicated 
time points. Culture medium was changed once after 24 h. 
  
 Figure S5. Related to Figure 4E,F. Epigenetic analysis of fumarate-induced trained macrophages. β-glucan- and 
fumarate-induced epigenetic changes. (A) Boxplots of H3K4me3 and H3K27ac reads/peak for fumarate “up” and fumarate 
“down” peaks. (B) Dynamic H3K4me3 and H3K27ac peaks (genomic regions with signal) were assigned to the nearest 
protein-coding gene using GREAT (http://bejerano.stanford.edu/great/public/html/). The top pathways from GREAT or 
DAVID gene ontology tools are shown as a table. Selected genes in the top pathways are also shown. (C) Heat map showing 
H3K27ac signal intensity at regions that are modulated by β-glucan (“BG up” and “BG down”) or fumarate (“Fumarate up” 
and “Fumarate down”). Each row of the heat map is a peak, and the y axis shows distance from the center of the peak (+/- 
12kb). The height of the heat map corresponds to the number of peaks. 
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Figure S6. Related to Figure 5. Modulatation of epigenetic enzymes by fumarate. Human monocytes were stimulated for 4 
h, 12 h, and 24 h with 50 μM fumarate, after which mRNA was isolated and expression of histone methyltransferases or 
demethylases was determined. Or human monocytes were trained with β-glucan. After 24h cells were washed and after 5 days 
of rest KDM5 expression was determined.  
 
 
 
 
  
Supplemental Tables 
Table S1, related to Figure 1 and Figure S1. Pathway enrichment based on the metabolomics data constructed with the 
MetaboAnalyst tool (with all  measured metabolites as a background). Raw data intensities were used for analysis. Details of 
the procedure are described in Methods. 
Table S2, related to Figure 1 and Figure S1. Pathway enrichment of upregulated metabolites based on the 
metabolomics data constructed with the Pathway-tools tool. Metabolites were considered significant if they have a FDR 
(Benjamini-Hochberg) of < 0.1. Details of the procedure are described in Methods. 
Table S3, related to Figure 1 and Figure S1. Pathway enrichment based on the transcriptomics data constructed with 
the Pathway-tools tool. Genes were considered significant if they have a FDR (Benjamini-Hochberg) of < 0.1.  Details of the 
procedure are described in Methods. 
Table S4, related to Figure 6. Primers used for qPCR. 
Epigenetic promoter primers 
Gene  Forward (5'-->3') Reverse (5'-->3') 
Myoglobulin AGCATGGTGCCACTGTGCT GGCTTAATCTCTGCCTCATGAT 
H2B TGTACTTGGTGACGGCCTTA CATTACAACAAGCGCTCGAC 
TNF GTGCTTGTTCCTCAGCCTCT ATCACTCCAAAGTGCAGCAG 
IL6 AGGGAGAGCCAGAACACAGA GAGTTTCCTCTGACTCCATCG 
   
   qPCR primers 
Gene  Forward (5'-->3') Reverse (5'-->3') 
B2M ATGAGTATGCCTGCCGTGTG CCAAATGCGGCATCTTCAAAC 
HPRT CCTGGCGTCGTGATTAGTGAT AGACGTTCAGTCCTGTCCATAA 
Hexokinase2 TTGACCAGGAGATTGACATGGG CAACCGCATCAGGACCTCA 
ALDOA CAGGGACAAATGGCGAGACTA GGGGTGTGTTCCCCAATCTT 
ENO1 TGGTGTCTATCGAAGATCCCTT CCTTGGCGATCCTCTTTGG 
LDHA ATGGCAACTCTAAAGGATCAGC CCAACCCCAACAACTGTAATCT 
KDM5a AGCCGAGTTGGGAGGAGTT TGGACTCTTGGAGTGAAACGA 
KDM5b CCATAGCCGAGCAGACTGG GGATACGTGGCGTAAAATGAAGT 
KDM5c GGGTCCGACGATTTCCTACC ATGCCCGATTTCTCTGCGATG 
KDM5d CAAGACCCGCTTGGCTACATT TTGGACGCGAGGAGTAAATCT 
KDM3a GTGCTCACGCTCGGAGAAA GTGGGAAACAGCTCGAATGGT 
KDM6b CACCCCAGCAAACCATATTATGC CACACAGCCATGCAGGGATT 
 
